Literature DB >> 27102030

Effectiveness of a Community-Based Intervention Program to Reduce Hypertension Prevalence Among Adults: Results of a Quasiexperimental Study With Control Group in the Region of Sousse, Tunisia.

Jihene Sahli1, Jihene Maatoug2, Imed Harrabi1, Sihem Ben Fredj1, Emna Dendana1, Hassen Ghannem1.   

Abstract

BACKGROUND: High blood pressure is preventable and is directly related to lifestyle habits such as an unbalanced diet, low levels of physical activity, and tobacco use.
OBJECTIVES: This quasiexperimental study aimed to assess the effectiveness of a 3-year community intervention targeting healthy lifestyle promotion in reducing hypertension prevalence among adults.
METHODS: A quasiexperimental design was used to evaluate the effectiveness of a 3-year intervention for healthy lifestyle that was implemented between 2010 and 2013 in a community of adults in the region of Sousse in Tunisia. The population study was randomly selected in both intervention and control groups at pre-assessment and post-assessment. After considering a type 1 error α of 5%, a type 2 error β of 20%, and a change in the prevalence of various risk factors of 6% between pre-intervention and post-intervention, the sample size was fixed to 2,000 adults in intervention and control areas.
RESULTS: The intervention group was composed of 940 and 1,001 adults, and the control group was composed of 940 and 976, respectively, at pre-assessment and post-assessment. The prevalence of hypertension decreased in the intervention group globally from 37.3% to 33.7% but not significantly (p = 0.1). In the control group, this proportion increased from 31.1% to 33.4% without significant difference (p = 0.28). In the intervention group, after stratification for age, a significant decrease (p = 0.007) in the prevalence of hypertension was observed for participants younger than 40 years old: it decreased from 22.8% to 16.2%. In the control group, it increased from 14% to 15.4% (p = 0.52). In intervention group, a significant decrease of the hypertension from 31.4% to 26% (p = 0.03) was observed among nonobese participants after stratification for weight status. No significant change was observed in the control group.
CONCLUSIONS: This study showed the feasibility and effectiveness of a community-based intervention to reduce the prevalence of hypertension in the context of a developing country.
Copyright © 2016 World Heart Federation (Geneva). Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27102030     DOI: 10.1016/j.gheart.2016.01.001

Source DB:  PubMed          Journal:  Glob Heart


  5 in total

1.  Health promotion interventions for the control of hypertension in Africa, a systematic scoping review from 2011 to 2021.

Authors:  Jinhee Shin; Kennedy Diema Konlan; Eugenia Mensah
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.240

2.  A Cross-Sectional Study on Hypertension Medication Adherence in a High-Burden Region in Namibia: Exploring Hypertension Interventions and Validation of the Namibia Hill-Bone Compliance Scale.

Authors:  Olivia Nakwafila; Tivani Mashamba-Thompson; Anthony Godi; Benn Sartorius
Journal:  Int J Environ Res Public Health       Date:  2022-04-06       Impact factor: 3.390

3.  Interventions in hypertension: systematic review and meta-analysis of natural and quasi-experiments.

Authors:  Tong Xia; Fan Zhao; Roch A Nianogo
Journal:  Clin Hypertens       Date:  2022-05-01

4.  PASCAR and WHF Cardiovascular Diseases Scorecard project.

Authors:  Habib Gamra; Jihene Maatoug; Jean M Fourie; Wihan Scholtz; Oana Scarlatescu; George Nel; Hassen Ghannem
Journal:  Cardiovasc J Afr       Date:  2020 Sep/Oct       Impact factor: 1.167

Review 5.  Interventions targeting hypertension and diabetes mellitus at community and primary healthcare level in low- and middle-income countries:a scoping review.

Authors:  Jorge César Correia; Sarah Lachat; Grégoire Lagger; François Chappuis; Alain Golay; David Beran
Journal:  BMC Public Health       Date:  2019-11-21       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.